|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows used in operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance cost | |||||
| Capitalized paid-in-kind (PIK) interest | |||||
| Accretion of exit fee | |||||
| Stock-based compensation | |||||
| Loss on exchange of warrants | |||||
| Change in fair value of warrant liabilities | |||||
| Change in fair value of debentures | |||||
| New Convertible Secured Debentures | |||||
| November 2024 Debentures | |||||
| Total change in fair value of debentures | |||||
| Loss on extinguishment of debt | |||||
| Induced conversion expense | |||||
| Non-cash lease expense | |||||
| Interest expense assumed into Convertible Senior Secured Term Loan | |||||
| Convertible Senior Secured Term Loan | |||||
| Total interest expense assumed into Convertible Senior Secured Term Loan | |||||
| Impairment of property and equipment | |||||
| Settlement of liquidated damages with Common Stock | |||||
| Loss on disposal of assets | |||||
| Loss on lease termination | |||||
| Gain on short-term investments | |||||
| Change in fair value of warrant liabilities | |||||
| Inventory write-off | |||||
| Other notes payable adjustments | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Contract assets | |||||
| Prepaid expenses and other assets | |||||
| Other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Franchise tax payable | |||||
| Contract liabilities | |||||
| Operating lease liabilities | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from (used in) investing activities: | |||||
| Capital expenditures | |||||
| Acquisition of business, net of cash acquired | |||||
| Proceeds from sale of assets held for sale | |||||
| Proceeds from sale of property and equipment | |||||
| Proceeds from sale of short-term investments | |||||
| Purchase of short-term investments | |||||
| Net cash from (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from notes payable | |||||
| Payment of debt issuance costs on notes payable | |||||
| Notes Payable to Banks | |||||
| Total payment of debt issuance costs on notes payable | |||||
| Proceeds from November 2024 Debentures | |||||
| Proceeds from At the Market (ATM) offering, net | |||||
| Proceeds from issuance of debentures and SPA Warrants, net of discount | |||||
| Payment of ATM commissions and fees | |||||
| Proceeds from exercise of stock options | |||||
| Issuance of Series B Preferred Stock | |||||
| Repayment on Ameristate Loan | |||||
| Proceeds from reverse recapitalization with CleanTech Acquisition Corp, net | |||||
| Net cash from financing activities | |||||
| Effect of changes in exchange rates on cash and cash equivalents | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for taxes | |||||
| Non-cash investing and financing activities: | |||||
| Conversion of Term Loan notes and interest to common stock | |||||
| Conversion of convertible debt to Common Stock | |||||
| Conversion of preferred stock in connection with reverser recapitalization | |||||
| Series A Preferred Stock | |||||
| Series B Preferred Stock | |||||
| Private and Public Warrant Liabilities assumed in reverse recapitalization | |||||
| Fair value of SPA warrants at issuance | |||||
| Issuance of Series B preferred stock | |||||
| Preferred stock issued in exchange for convertible debt | |||||
| Exchange of Convertible Secured Debentures to Series A Preferred Stock | |||||
| Conversion of Series A Preferred Stock to Common Stock | |||||
| Total preferred stock issued in exchange for convertible debt | |||||
| Transfer from inventories to property and equipment | |||||
| Transfer from property and equipment to assets held for sale | |||||
| Capital expenditures included in accounts payable | |||||
| Earnout shares for acquisition | |||||
| Debt assumed in acquisition | |||||
| Accrued purchase price | |||||
| Preferred stock dividend | |||||
| Deemed dividend | |||||
| Exchange of convertible debt and accrued interest expense to preferred stock | |||||
| Exercise of warrants | |||||
| Liabilities relieved through sale of assets held for sale | |||||
| Transfer from assets held for sale to property and equipment | |||||
| Operating leases at inception | |||||
Loading...